TB
Therini Bio, Inc.
SEC filingBiotechnology · Sacramento, CA
Amount raised$74.9Msold at filing
Total offering$80.8M$5.9M still open
Investors in the raise17count reported to the SEC
FiledSep 8, 2025first sale Mar 29, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Olga D DanilchankaDirector
Laia D Crespo-MartinDirector
Leslie D SchulzeExecutive Officer
Daniel D BurgessDirector
Michael D RossDirector
Laurence BarkerDirector
Tara NickersonExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.